Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma.

about

Clinicopathological significance of CHFR methylation in non-small cell lung cancer: a systematic review and meta-analysis.New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.In Vivo SELEX of an Inhibitory NSCLC-Specific RNA Aptamer from PEGylated RNA Library.

P2860

Q47193635-6D342D29-9BDA-41EE-8D70-B976AB081139 Q47221234-E0B266F0-AF1B-461D-8C59-AF5AC1BFCFE6 Q49196378-6C12F309-6B5C-4C47-951C-67FE9640CCF2

P2860

Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma.

Item

http://www.wikidata.org/entity/Q39178484

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma.

@en

Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma.

@nl

type

Item

label

Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma.

@en

Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma.

@nl

prefLabel

Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma.

@en

Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma.

@nl

P1476

Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma.

@en

P2093

Antoinette J Wozniak

http://www.w3.org/2001/XMLSchema#string

Manish K Thakur

http://www.w3.org/2001/XMLSchema#string

P2860

A comprehensive pathway map of epidermal growth factor receptor signaling

ErbB receptors: from oncogenes to targeted cancer therapies

Structural basis for EGF receptor inhibition by the therapeutic antibody IMC-11F8

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study.

Comprehensive genomic characterization of squamous cell lung cancers.

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship

Cancer statistics, 2016

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer.

Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.

P304

13-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/LCTT.S104207

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28293124

http://www.w3.org/2001/XMLSchema#string

P932

5342611

http://www.w3.org/2001/XMLSchema#string

Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma.

about

P2860

P2860

Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932